Visible Genomics

Preventing Vision Loss with a Simple Genetic Test

Print
Claim My Business
Min Investment
$493
Location
Oakbrook Terrace, IL
Expected Close Date
November 05, 2024
Target Raise
$15.00K-$1.23M
Security Price
$9.48
Number of Employees
2
Cash
$3,808
Revenue
$31,768
Short Term Debt
$2,004,044
Cost of Goods
$26,490
Long Term Debt
$0
Net Income
$-600,827

Company Description

Visible Genomics is an early-growth stage genetics-based testing and risk assessment company with a focus on severe ocular diseases. Our signature product, AMDiGuard™, is a simple cheek swab test that uses advanced DNA analysis and proprietary algorithms to assess risk and analyze progression of age-related macular degeneration (AMD), empowering medical professionals and patients to potentially delay or prevent disease onset.
Amount Raised : $15,169
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Research Reports

No reports have been submitted

Become a Reporter

0 Comments